Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Cell-surface marker discovery for lung cancer.

Cohen AS, Khalil FK, Welsh EA, Schabath MB, Enkemann SA, Davis A, Zhou JM, Boulware DC, Kim J, Haura EB, Morse DL.

Oncotarget. 2017 Dec 7;8(69):113373-113402. doi: 10.18632/oncotarget.23009. eCollection 2017 Dec 26.

2.

Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.

Cohen AS, Patek R, Enkemann SA, Johnson JO, Chen T, Toloza E, Vagner J, Morse DL.

Bioconjug Chem. 2016 Feb 17;27(2):427-38. doi: 10.1021/acs.bioconjchem.5b00516. Epub 2015 Oct 30.

3.

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

Tafreshi NK, Silva A, Estrella VC, McCardle TW, Chen T, Jeune-Smith Y, Lloyd MC, Enkemann SA, Smalley KS, Sondak VK, Vagner J, Morse DL.

Mol Pharm. 2013 Aug 5;10(8):3175-85. doi: 10.1021/mp400222j. Epub 2013 Jul 8.

4.

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

Hopewell EL, Zhao W, Fulp WJ, Bronk CC, Lopez AS, Massengill M, Antonia S, Celis E, Haura EB, Enkemann SA, Chen DT, Beg AA.

J Clin Invest. 2013 Jun;123(6):2509-22. doi: 10.1172/JCI67250. Epub 2013 May 1.

5.

Transcriptional response of the sulfur chemolithoautotroph Thiomicrospira crunogena to dissolved inorganic carbon limitation.

Dobrinski KP, Enkemann SA, Yoder SJ, Haller E, Scott KM.

J Bacteriol. 2012 Apr;194(8):2074-81. doi: 10.1128/JB.06504-11. Epub 2012 Feb 10.

6.

Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter BW, Vagner J, Grobmyer SR, Gillies RJ, Morse DL.

Clin Cancer Res. 2012 Jan 1;18(1):207-19. doi: 10.1158/1078-0432.CCR-11-0238. Epub 2011 Oct 20. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1483. Gobmyer, Stephen R [corrected to Grobmyer, Stephen R].

7.

Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer.

Kao WH, Riker AI, Kushwaha DS, Ng K, Enkemann SA, Jove R, Buettner R, Zinn PO, Sánchez NP, Villa JL, D'Andrea AD, Sánchez JL, Kennedy RD, Chen CC, Matta JL.

J Invest Dermatol. 2011 Oct;131(10):2139-42. doi: 10.1038/jid.2011.181. Epub 2011 Jun 23. No abstract available.

8.

A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.

Tafreshi NK, Enkemann SA, Bui MM, Lloyd MC, Abrahams D, Huynh AS, Kim J, Grobmyer SR, Carter WB, Vagner J, Gillies RJ, Morse DL.

Cancer Res. 2011 Feb 1;71(3):1050-9. doi: 10.1158/0008-5472.CAN-10-3091. Epub 2010 Dec 17.

9.

Genome-wide gene expression profiling reveals aberrant MAPK and Wnt signaling pathways associated with early parthenogenesis.

Liu N, Enkemann SA, Liang P, Hersmus R, Zanazzi C, Huang J, Wu C, Chen Z, Looijenga LH, Keefe DL, Liu L.

J Mol Cell Biol. 2010 Dec;2(6):333-44. doi: 10.1093/jmcb/mjq029. Epub 2010 Oct 6.

PMID:
20926514
10.

Standards affecting the consistency of gene expression arrays in clinical applications.

Enkemann SA.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1000-3. doi: 10.1158/1055-9965.EPI-10-0044. Epub 2010 Mar 23. Review.

11.

ChIP-on-Chip Analysis methods for Affymetrix Tiling Arrays.

Yoder SJ, Enkemann SA.

Methods Mol Biol. 2009;523:367-81. doi: 10.1007/978-1-59745-190-1_24.

PMID:
19381926
12.

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG.

Nat Med. 2008 Aug;14(8):822-7. doi: 10.1038/nm.1790. Epub 2008 Jul 20.

13.

The impact of genomics in understanding human melanoma progression and metastasis.

Ren S, Liu S, Howell P Jr, Xi Y, Enkemann SA, Ju J, Riker AI.

Cancer Control. 2008 Jul;15(3):202-15. Review.

PMID:
18596672
14.

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J.

BMC Med Genomics. 2008 Apr 28;1:13. doi: 10.1186/1755-8794-1-13.

16.

Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.

Zhang X, Li P, Bao J, Nicosia SV, Wang H, Enkemann SA, Bai W.

J Biol Chem. 2005 Oct 21;280(42):35458-68. Epub 2005 Aug 10.

17.

Transcriptional profile of NeuroD expression in a human fetal astroglial cell line.

Kamath SG, Chen N, Enkemann SA, Sanchez-Ramos J.

Gene Expr. 2005;12(2):123-36.

18.

Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.

Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, Yeatman TJ.

Clin Cancer Res. 2005 Apr 1;11(7):2478-85.

19.
20.

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

Dobbin KK, Beer DG, Meyerson M, Yeatman TJ, Gerald WL, Jacobson JW, Conley B, Buetow KH, Heiskanen M, Simon RM, Minna JD, Girard L, Misek DE, Taylor JM, Hanash S, Naoki K, Hayes DN, Ladd-Acosta C, Enkemann SA, Viale A, Giordano TJ.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):565-72.

21.

Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples.

Centeno BA, Enkemann SA, Coppola D, Huntsman S, Bloom G, Yeatman TJ.

Cancer. 2005 Apr 25;105(2):101-9.

22.

Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.

Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH, Saporta S, Boulware D, Moscinski L, Alsina M, Dalton WS.

Cancer Res. 2003 Nov 15;63(22):7900-6.

23.

New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2.

Tsibris JC, Maas S, Segars JH, Nicosia SV, Enkemann SA, O'Brien WF, Spellacy WN.

Biochem Biophys Res Commun. 2003 Dec 5;312(1):249-54.

PMID:
14630051
24.

Role of Gadd45alpha in the density-dependent G1 arrest induced by p27(Kip1).

Zhang X, Ma L, Enkemann SA, Pledger WJ.

Oncogene. 2003 Jul 3;22(27):4166-74.

PMID:
12833139
25.

Mobility within the nucleus and neighboring cytosol is a key feature of prothymosin-alpha.

Enkemann SA, Ward RD, Berger SL.

J Histochem Cytochem. 2000 Oct;48(10):1341-55.

PMID:
10990488
26.

Functional discontinuities in prothymosin alpha caused by caspase cleavage in apoptotic cells.

Enkemann SA, Wang RH, Trumbore MW, Berger SL.

J Cell Physiol. 2000 Feb;182(2):256-68.

PMID:
10623890
27.

Does prothymosin alpha affect the phosphorylation of elongation factor 2?

Enkemann SA, Pavur KS, Ryazanov AG, Berger SL.

J Biol Chem. 1999 Jun 25;274(26):18644-50.

28.

Metabolic regulation of protein-bound glutamyl phosphates: insights into the function of prothymosin alpha.

Tao L, Wang RH, Enkemann SA, Trumbore MW, Berger SL.

J Cell Physiol. 1999 Feb;178(2):154-63.

PMID:
10048579
29.

Prothymosin alpha in vivo contains phosphorylated glutamic acid residues.

Trumbore MW, Wang RH, Enkemann SA, Berger SL.

J Biol Chem. 1997 Oct 17;272(42):26394-404.

30.

Supplemental Content

Loading ...
Support Center